Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam

Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science

Mouse Anti-HLA DQ1, HLA DQ3 Monoclonal Antibody, Unconjugated, Clone HL-37 from Abcam

T4 DNA Ligase (HC) from Invitrogen

Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science Mouse Anti-HLA DQ1, HLA DQ3 Monoclonal Antibody, Unconjugated, Clone HL-37 from Abcam T4 DNA Ligase (HC) from Invitrogen

(Date:11/26/2009)...eir impressive antlers, red deer have been caught ...,s antlers are much more than decorative. They are...lling. John Currey, from The University of York, U... of bone for over half a century and has become fa...rough a long-standing collaboration with Tomas Lan...

(Date:11/26/2009)...llin-resistant Staphylococcus Aureus ) and other ... low-temperature plasma prototype devices have bee...ng bactericidal cocktails. , Two prototype devic...tion of healthy skin (e.g. hands and feet) in hosp...lethal threat; and another to shoot bacteria-killi...

(Date:11/25/2009)...arisch, Head of the Cell Death Research Laboratory...y, has been awarded the prestigious Johnson & John...ng the cause of brain cell damage in Parkinson,s d...cientists in support of innovation and excellence ...conferred earlier this month at an event at the Hy...

Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2 Plasma produces KO cocktail for MRSA 2 Plasma produces KO cocktail for MRSA 3 Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2 Environmental health chief in Milwaukee to hear citizen concerns 10107 1 Environmental health chief in Milwaukee to hear citizen concerns 10107 2 Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 1 Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 2 Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 3 New Hope for Treatment of Pancreatic Cancer 58340 1 New Hope for Treatment of Pancreatic Cancer 58340 2

[1] Tough yet stiff deer antler is materials scientist's dream [0] Plasma produces KO cocktail for MRSA [0] Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's

...grow plant material and burn it. If managed well m... will be captured by the growing plants, and so ha...arbon dioxide. , Better still, the growing plants...roblems. In a review of current systems, Gran Bern...at Chalmers University of Technology in Gtenborg, ...

... flown to Mongolia the past three summers to searc...ld crew have joined him at Montana State Universit...n paleontologists. , Horner is Ameya Preserve cur...s and Regents Professor of Paleontology in Montana...eontology to be developed better," said Bolortsets...

...fference in the way males and females respond to c...plain why men are more prone to liver cancer, acco...nome-wide study that helps explain why there is su...e organ, where you wouldn,t expect to see one, sai...d lead author of a paper that appeared last month ...

Other Biology News:Biomass production -- careful planning can bring many benefits 2 Mongolian paleontologists with a dream come to Montana State University 2 Mongolian paleontologists with a dream come to Montana State University 3 MIT: Why men are more prone to liver cancer 2

Biomass production -- careful planning can bring many benefits Mongolian paleontologists with a dream come to Montana State University MIT: Why men are more prone to liver cancer

(Date:11/24/2009)...FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiophar...zingnovelpainmanagementtherapies,announcedtodaytha...isscheduledtopresentatthe21stAnnualPiperJaffrayHea...YorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTonno...ailabletorespondtoquestionsduringthepresentationsa...

(Date:11/24/2009)...rbleEnergyCorp.announcedtodaythatthecompanyandtheO...warded$2millionbyWashingtonState,sCommunityEconomi...shiptoconstructthestate,sfirstspecialtybiochemical...ntwillsignificantlyspeedthedevelopmentofourbiorefi...ueMarbleEnergyCEOKellyOgilvie."WearegratefultotheG...

(Date:11/24/2009)...orpatientswithadvanced-stage,orrecurrentendometria...Call/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(t...donendocrinetherapyandoncology,todayannouncedposit...toxicpeptideconjugate,AEZS-108(formerlyAN-152),inp...apersonalizedhealthcareapproach,thestudyselectedpa...

(Date:11/24/2009)...Call/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobal...hatithassubmittedaMAAtotheEuropeanMedicinesAgencyf...therapyindevelopment,forthetreatmentofType1Gaucher...glucerasealfathathasbeensubmitted,withprevious,sub...aglobalsupplyshortageofthecurrentlyapprovedandmark...

Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2 NeurogesX to Present at Piper Jaffray Health Care Conference 3 Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3

[0] NeurogesX to Present at Piper Jaffray Health Care Conference [0] Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board [0] AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease

Products	Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam
Company	Abcam
Item	Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4
Price
Description	Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 (Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 Swiss Protein ID: P05783
Info	Abcam 332 Cambridge Science Park Milton Road Cambridge CB4 0FW UK Customer Service: +44 (0) 1223 472030 Fax Number: +44 (0) 1223 472038 Web Site: http://www.abcam.com